VSMD Stock Chart & Stats
$0.04
$0.00(0.00%)
At close: 4:00 PM EDT
$0.04
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.04 - $0.04
Previous CloseN/A
Volume6.67K
Average Volume (3M)0.00
Market Cap
$8.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding8,011,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VSMD FAQ
What was Vasamed Inc’s price range in the past 12 months?
Vasamed Inc lowest stock price was $0.04 and its highest was $0.04 in the past 12 months.
What is Vasamed Inc’s market cap?
Vasamed Inc’s market cap is $8.00.
When is Vasamed Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vasamed Inc’s earnings last quarter?
Currently, no data Available
Is Vasamed Inc overvalued?
According to Wall Street analysts Vasamed Inc’s price is currently Overvalued.
Does Vasamed Inc pay dividends?
Vasamed Inc does not currently pay dividends.
What is Vasamed Inc’s EPS estimate?
Vasamed Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vasamed Inc have?
Vasamed Inc has 8,011,000 shares outstanding.
What happened to Vasamed Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vasamed Inc?
Currently, no hedge funds are holding shares in VSMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vasamed Inc
Vasamed, Inc. specializes in the development, manufacturing, licensing, and distribution of a comprehensive suite of products, software solutions, and services focused on the assessment and management of circulatory health throughout the United States. Key among its offerings is the SensiLase PAD-IQ, a device designed to measure skin perfusion pressure, conduct pulse volume recordings, and calculate the Ankle-Brachial Index utilizing Doppler-derived pressure readings. The company also provides advanced Wound Imaging & SmartDraw systems for precise wound measurement. Additionally, Vasamed offers the PAD-IQ Studycast, a platform that facilitates the rapid and secure transmission of diagnostic test results to vascular specialists. This enables prompt interpretation of findings and supports timely, medically indicated therapeutic interventions. For safeguarding its equipment, the company also supplies a custom carrying case for the PAD-IQ system. Vasamed caters to both clinicians and patients, and has been operating since its founding in 1988. Its corporate headquarters are located in Eden Prairie, Minnesota.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
0.61% Other Institutional Investors
99.39% Public Companies and
Individual Investors